S24-4 Perspective of Benefit Risk Evaluation in Post-Marketing

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.42.101
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

S8-1. Post-Marketing Surveillance --From Corporate Perspective--

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2010English

Evaluation of Green Marketing Performance: A Methodological Perspective

Scientific Conference on Economics and Entrepreneurship Proceedings
2020English

Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Utility of Registries for Post-Marketing Evaluation of Medicines. A Survey of Swedish Health Care Quality Registries From a Regulatory Perspective

Upsala Journal of Medical Sciences
Medicine
2017English

Balancing Risk Versus Benefit: The Elderly Patient's Perspective on Warfarin Therapy

Pharmacy Practice
Pharmaceutical SciencePharmacy
2009English

Urban Environmental With Evaluation on Cost, Benefit and Risk

ENVIRONMENTAL SYSTEMS RESEARCH
1996English

Post-Marketing Surveillance

English

A Post Marketing Evaluation of the Efficacy of Rapid Recovery in Reducing Symptoms of Hangover

Clinical Research and Trials
2018English

Marketing Mix 7Ps in Islamic Perspective

KnE Social Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy